Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Michigan Rogel Cancer Center
Travera Inc
Stanford University
Hoffmann-La Roche
Endeavor Biomedicines, Inc.
ViroMissile, Inc.
Children's Oncology Group
St. Jude Children's Research Hospital
University of Nebraska
National Cancer Institute (NCI)
AccSalus Biosciences, Inc.
Cancer Research UK
Massive Bio, Inc.
Day One Biopharmaceuticals, Inc.
JS InnoPharm, LLC
University Health Network, Toronto
National Cancer Institute (NCI)
Purple Biotech Ltd.
Aminex Therapeutics, Inc.
Taproot Health
Rain Oncology Inc
RECORDATI GROUP
Mayo Clinic
Hoffmann-La Roche
Xencor, Inc.
Provectus Pharmaceuticals
Novartis
Infinity Pharmaceuticals, Inc.
EMD Serono
SpeciCare
Fore Biotherapeutics
Central Hospital, Nancy, France
Ohio State University Comprehensive Cancer Center
University of California, San Francisco
Virginia Commonwealth University
Merck Sharp & Dohme LLC
Yale University
INSYS Therapeutics Inc
Delcath Systems Inc.
National Cancer Institute (NCI)
Novartis
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Exelixis
Rutgers, The State University of New Jersey
Mannkind Corporation